Artesunate Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Artesunate Market covers analysis By Type (0.99, 0.98); Form (Tablets, Injection) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00020509
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION

Artesunate (AS) is a medication that is used to treat malaria. The intravenous form is preferred to quinine for severe malaria. Often it is used as part of combination therapy, such as artesunate plus mefloquine. It is not used for the prevention of malaria. Artesunate/amodiaquine, sold under the trade name Camoquin, is a medication used for the treatment of malaria.

MARKET DYNAMICS

The Artesunate market is driving due to the rising prevalence of malaria. Moreover, the expenditure in research and development of drug will create lucrative opportunity in growth of this market.

MARKET SCOPE

The "Artesunate Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with/ a special focus on the global market trend analysis. The report aims to provide an overview of Artesunate market with detailed market segmentation by, form and by type and form. The Artesunate market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Artesunate Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Artesunate market is segmented on the basis of type and form. Based on type, the market is segmented as 0.99, 0.98. Based on form the market is segmented into Tablets, Injection

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Artesunate Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Artesunate Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Artesunate Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the Artesunate Market in these regions.

Artesunate Market Report Analysis

Artesunate Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • NHU
  • Guilin Pharma
  • KPC Pharmaceuticals
  • Nanjing Hicin Pharmaceutical
  • Fuyuan Pharmaceuticals
  • Kunming Baker Norton Pharmaceutical
  • MCW Healthcare
  • Shin Poong
  • Ipca Laboratories

Regional Overview

Regional Overview
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Market Segment By Type
  • 0.99
  • 0.98
Market Segment By Form
  • Tablets
  • Injection
MARKET PLAYERS


The report covers key developments in the Artesunate Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Artesunate Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Artesunate Market in the global market. Below mentioned is the list of few companies engaged in the Artesunate market.

The report also includes the profiles of key players in Artesunate market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   NHU
  •   Guilin Pharma
  •   KPC Pharmaceuticals
  •   Nanjing Hicin Pharmaceutical
  •   Fuyuan Pharmaceuticals
  •   Kunming Baker Norton Pharmaceutical
  •   MCW Healthcare
  •   Shin Poong
  •   Ipca Laboratories
  •   Acino
  •   Sanofi Aventis
  •   Cipla
  •   Ajanta Pharma
  •   Amivas
  •   Systacare Remedies

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Artesunate Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • 0.99
  • 0.98
By Form
  • Tablets
  • Injection
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • NHU
  • Guilin Pharma
  • KPC Pharmaceuticals
  • Nanjing Hicin Pharmaceutical
  • Fuyuan Pharmaceuticals
  • Kunming Baker Norton Pharmaceutical
  • MCW Healthcare
  • Shin Poong
  • Ipca Laboratories
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1. NHU
    2. Guilin Pharma
    3. KPC Pharmaceuticals
    4. Nanjing Hicin Pharmaceutical
    5. Fuyuan Pharmaceuticals
    6. Kunming Baker Norton Pharmaceutical
    7. MCW Healthcare
    8. Shin Poong
    9. Ipca Laboratories
    10. Acino
    11. Sanofi Aventis
    12. Cipla
    13. Ajanta Pharma
    14. Amivas
    15. Systacare Remedies